D-Wave Quantum falls nearly 3% as earnings miss overshadows revenue beat
Investing.com - Clover Health Investments (NASDAQ: CLOV) reported second quarter EPS of $0.0336, $0.05 better than the analyst estimate of $-0.0187. Revenue for the quarter came in at $477.62M versus the consensus estimate of $468.3M.
Guidance
Clover Health Investments sees FY 2025 revenue of $1.8000B-$1.8800B versus the analyst consensus of $1.8600B.
Clover Health Investments’s stock price closed at $2.85. It is down -18.8000% in the last 3 months and up 71.1700% in the last 12 months.
Clover Health Investments saw 0 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Clover Health Investments’s stock price’s past reactions to earnings here.
According to InvestingPro, Clover Health Investments’s Financial Health score is "great performance".
Check out Clover Health Investments’s recent earnings performance, and Clover Health Investments’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar